Drug Profile
FMP 2.1 malaria vaccine
Alternative Names: FMP2.1/AS02A; FMP 2.1-AS02A-malaria-vaccine; FMP2.1; FMP2.1 vaccineLatest Information Update: 10 Jul 2023
Price :
$50
*
At a glance
- Originator United States Army Medical Research and Materiel Command; Walter Reed Army Institute of Research
- Developer GSK; National Institute of Allergy and Infectious Diseases; United States Army Medical Research and Materiel Command; University of Maryland, Baltimore; Walter Reed Army Institute of Research
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 25 Jun 2015 Discontinued - Phase-I for Malaria (In children, In infants, Prevention) in Mali (IM)
- 25 Jun 2015 Discontinued - Phase-I for Malaria (Prevention) in Mali (IM)
- 25 Jun 2015 Discontinued - Phase-I/II for Malaria (Prevention) in USA (IM)